Serving tech enthusiasts for over 25 years.
TechSpot means tech analysis and advice you can trust.
What just happened? Science Corp. recently confirmed that PRIMA is officially launching in 30 European countries, promising an effective solution for vision loss caused by geographic atrophy (GA), a condition associated with age-related macular degeneration (AMD). Science said AMD-related GA is a leading cause of blindness, and the PRIMA device has already demonstrated its ability to essentially restore sight in blind seniors.
Science describes PRIMA as an "investigational" retinal implant designed to combat vision loss caused by GA and AMD. For the time being, the device is commercially available only in the European market. The implant is actually part of a more complex system that includes both a subretinal photovoltaic chip and a pair of specialized glasses.
The glasses are designed to "project" near-infrared light signals onto the subretinal implant, which then converts the signals into electrical stimulation that is transmitted to the brain. The result is intended to give patients the ability to see shapes, letters, and other "real" objects again despite damage to the retinal cells. Science said the system even includes a "zoom-in" feature that allows patients to magnify letters while reading.
